LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 78 of 87
Next
>>
>
1926 to 1950 of 2160 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Mitoxantrone	10.0	uM	LJP6	3	C19	72	hr	1657	991	5505	0.1800	-0.1733
BT-20	MK2206	10.0	uM	LJP6	1	F01	72	hr	1657	1794	5505	0.3259	0.0354
BT-20	MK2206	10.0	uM	LJP6	2	F01	72	hr	1657	1804	5505	0.3277	0.0380
BT-20	MK2206	10.0	uM	LJP6	3	F01	72	hr	1657	1918	5505	0.3484	0.0676
BT-20	Neratinib	10.0	uM	LJP5	1	A13	72	hr	1657	3203	5505	0.5818	0.4016
BT-20	Neratinib	10.0	uM	LJP5	2	A13	72	hr	1657	2698	5505	0.4900	0.2703
BT-20	Neratinib	10.0	uM	LJP5	3	A13	72	hr	1657	2750	5505	0.4995	0.2839
BT-20	Nilotinib	10.0	uM	LJP5	1	N13	72	hr	1657	1916	5505	0.3480	0.0671
BT-20	Nilotinib	10.0	uM	LJP5	2	N13	72	hr	1657	2224	5505	0.4040	0.1472
BT-20	Nilotinib	10.0	uM	LJP5	3	N13	72	hr	1657	2040	5505	0.3705	0.0993
BT-20	Nintedanib	10.0	uM	LJP6	1	H01	72	hr	1657	3064	5505	0.5565	0.3655
BT-20	Nintedanib	10.0	uM	LJP6	2	H01	72	hr	1657	3556	5505	0.6459	0.4933
BT-20	Nintedanib	10.0	uM	LJP6	3	H01	72	hr	1657	3377	5505	0.6134	0.4468
BT-20	NU7441	10.0	uM	LJP5	1	C07	72	hr	1657	2576	5505	0.4679	0.2386
BT-20	NU7441	10.0	uM	LJP5	2	C07	72	hr	1657	2310	5505	0.4196	0.1695
BT-20	NU7441	10.0	uM	LJP5	3	C07	72	hr	1657	2515	5505	0.4568	0.2228
BT-20	Dactolisib	10.0	uM	LJP5	1	M13	72	hr	1657	1934	5505	0.3513	0.0718
BT-20	Dactolisib	10.0	uM	LJP5	2	M13	72	hr	1657	1915	5505	0.3478	0.0669
BT-20	Dactolisib	10.0	uM	LJP5	3	M13	72	hr	1657	2081	5505	0.3780	0.1100
BT-20	NVP-TAE684	10.0	uM	LJP6	1	K13	72	hr	1657	1688	5505	0.3066	0.0079
BT-20	NVP-TAE684	10.0	uM	LJP6	2	K13	72	hr	1657	1496	5505	0.2717	-0.0420
BT-20	NVP-TAE684	10.0	uM	LJP6	3	K13	72	hr	1657	1630	5505	0.2961	-0.0072
BT-20	Palbociclib	10.0	uM	LJP6	1	E13	72	hr	1657	2229	5505	0.4049	0.1485
BT-20	Palbociclib	10.0	uM	LJP6	2	E13	72	hr	1657	2341	5505	0.4252	0.1776
BT-20	Palbociclib	10.0	uM	LJP6	3	E13	72	hr	1657	2443	5505	0.4437	0.2041

|<
<<
Previous
Page 78 of 87
Next
>>
>
1926 to 1950 of 2160 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)